85 related articles for article (PubMed ID: 3221755)
1. [The interaction of drugs acting predominantly on the CNS].
Zelikson IuI; Davydova ON
Med Sestra; 1988 Nov; 47(11):45-52. PubMed ID: 3221755
[No Abstract] [Full Text] [Related]
2. Centrally acting drugs.
Bateman DN; Chaplin S
Br Med J (Clin Res Ed); 1988 Feb; 296(6619):417-9. PubMed ID: 3125927
[No Abstract] [Full Text] [Related]
3. Drug development for CNS disorders: strategies for balancing risk and reducing attrition.
Pangalos MN; Schechter LE; Hurko O
Nat Rev Drug Discov; 2007 Jul; 6(7):521-32. PubMed ID: 17599084
[TBL] [Abstract][Full Text] [Related]
4. Drugs and mood changes.
Kitchen I
Nursing (Lond); 1984 Apr; 2(24):719-21. PubMed ID: 6563458
[No Abstract] [Full Text] [Related]
5. The role of pharmacogenetics in treating central nervous system disorders.
Patnaik M; Renda MJ; Athanasiou MC; Reed CR
Exp Biol Med (Maywood); 2008 Dec; 233(12):1504-9. PubMed ID: 18849543
[TBL] [Abstract][Full Text] [Related]
6. The use of central nervous system drugs and analgesics among very old people with and without dementia.
Lövheim H; Karlsson S; Gustafson Y
Pharmacoepidemiol Drug Saf; 2008 Sep; 17(9):912-8. PubMed ID: 18398935
[TBL] [Abstract][Full Text] [Related]
7. Polypharmacy in multiple sclerosis.
Myers LW; Phillips JT
Epilepsy Res Suppl; 1996; 11():181-95. PubMed ID: 9294736
[TBL] [Abstract][Full Text] [Related]
8. When breastfeeding mothers need CNS-acting drugs.
Rubin ET; Lee A; Ito S
Can J Clin Pharmacol; 2004; 11(2):e257-66. PubMed ID: 15591613
[TBL] [Abstract][Full Text] [Related]
9. [Drugs and traffic].
Mattila MJ
Duodecim; 1984; 100(19):1234-43. PubMed ID: 6510285
[No Abstract] [Full Text] [Related]
10. [New drugs in neurology].
Mattle HP
Praxis (Bern 1994); 1999 Apr; 88(18):827-34. PubMed ID: 10409881
[TBL] [Abstract][Full Text] [Related]
11. Drugs to treat Alzheimer's disease.
J Psychosoc Nurs Ment Health Serv; 2009 Apr; 47(4):13-4. PubMed ID: 19437925
[No Abstract] [Full Text] [Related]
12. [Use of neurotropic preparations for treating dermatoses].
Shakhnes IE
Vestn Dermatol Venerol; 1978 Aug; (8):53-6. PubMed ID: 358653
[No Abstract] [Full Text] [Related]
13. Role of pharmacogenetics in the use of CNS drugs: from drug pipeline to primary care?
Hopkins MM; Martin PA
Expert Rev Neurother; 2006 Dec; 6(12):1765-7. PubMed ID: 17181421
[No Abstract] [Full Text] [Related]
14. [On new mechanisms of action of centrally active drugs].
Castrén E; Panula P
Duodecim; 2003; 119(15):1487-95. PubMed ID: 14502828
[No Abstract] [Full Text] [Related]
15. Axel Unterbeck on memory, cognition and the development of CNS drugs. Interview by Steve Carney.
Unterbeck A
Drug Discov Today; 2005 Feb; 10(3):165-8. PubMed ID: 15708528
[No Abstract] [Full Text] [Related]
16. Challenges in the search for drugs to treat central nervous system disorders.
Enna SJ; Williams M
J Pharmacol Exp Ther; 2009 May; 329(2):404-11. PubMed ID: 19182069
[TBL] [Abstract][Full Text] [Related]
17. Prescribing CNS drugs for elderly patients.
Ghose K
Drugs Aging; 1994 Apr; 4(4):275-84. PubMed ID: 8019051
[No Abstract] [Full Text] [Related]
18. CNS-active drugs in aging population at high risk of cerebrovascular events: evidence from preclinical and clinical studies.
Zhao CS; Hartikainen S; Schallert T; Sivenius J; Jolkkonen J
Neurosci Biobehav Rev; 2008; 32(1):56-71. PubMed ID: 17599405
[TBL] [Abstract][Full Text] [Related]
19. Positive Beers criteria: limitations.
Linnebur SA; Vande Griend JP; Dugan JP; Page RL
Consult Pharm; 2009 Nov; 24(11):792; author reply 792, 794. PubMed ID: 20092217
[No Abstract] [Full Text] [Related]
20. Drug-drug interactions in older adults: which ones matter?
Hanlon JT; Schmader KE
Am J Geriatr Pharmacother; 2005 Jun; 3(2):61-3. PubMed ID: 16129382
[No Abstract] [Full Text] [Related]
[Next] [New Search]
